Analysis of haloperidol and its neurotoxic pyridinium metabolite in biological samples by liquid chromatography/mass spectrometry

Japanese Journal of Forensic Toxicology

Volumn 15, Issue 1, 1997, Pages 44-54

  Igarashi, Kazuo ^a   Sigee, Yoshihiko ^a   Kasuya, Fumiyo ^a   Fukui, Miyoshi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

haloperidol; high performance liquid chromatography; LC ESI MS; mass spectrometry; MPP+ like metabolite; neurotoxic metabolite; pyridinium metabolite

Indexed keywords

DRUG METABOLITE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RAT;

ANIMALIA;

EID: 0030942396     PISSN: 09159606     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baldessarini, R.J.: Drugs and the treatment of psychiatric disorders. In Gilman, A.G., Rall, T.W., Nies, A.S. and Taylor, P. (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed., Pergamon Press, New York, 1991, p. 400.
2. Waddington, J. L. : Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology, 101, 431-447 (1990).
3. Foreman, A. and Ohman, R. : Pharmacokinetic studies on haloperidol in man. Curr Ther Res, 20, 319-336 (1976).
4. Forsman, A. and Ohman, R. : Applied pharmacokinetics of haloperidol in man. Curr Ther Res, 21, 396-411 (1976).
5. Subramanyam, B., Pond, S.M., Eyles, D.W., Whiteford, H.A., Fouda, H.G. and Castagnoli, N., Jr. : Identification of a potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol. Biochem Biophys Res Commun, 181, 573-578 (1991).
6. Igarashi, K., Kasuya, F., Fukui, M., Abe, T. and Castagnoli, N. Jr. : Simultaneous determination of haloperidol and its neurotoxic metabolite in plasma and brain tissue from schizophrenic patients treated with haloperidol using HPLC and solid-phase extraction. Jpn J Forensic Toxicol, 13, 31-38 (1995).
7. Subramanyam, B., Rollema, H., Woolf, T. and Castagnoli, N., Jr. : Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats. Biochem Biophys Res Commun, 166, 238-244 (1990).
8. Fang, J. and Gorrod, J. W. : Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite. Toxicol Lett, 59, 117-123 (1991).
9. Markey, S. P. and Schmuff, N. R. : The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds. Medicinal Res Rev, 6, 389-429 (1986).
10. Langston, W. J. : Mechanism underlying neuronal degeneration in Parkinson's disease: an experimental and theoretical treatise. Movement Disorders Suppl, 14, S15-S25 (1989).
11. + found in rat brain following ip administration of HP. Life Sci, 57, 2439-2446 (1995).
12. + analogs and related charged species. J Med Chem, 33, 2221-2230 (1990).
13. +-like neurotoxicity of a pyridinium metabolite derived from haloperidol: In vivo microdialysis and in vitro mitochondrial studies. J Pharmacol Exp Ther, 268, 380-387 (1994).
14. Bloomquist, J., King, E., Wright, A., Mytilineoli, C., Kimura, K., Castagnoli, K. and Castagnoli, N., Jr. : 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: Cell culture and neurotransmitter uptake studies. J Pharmacol Exp Ther, 270, 822-833 (1994).
15. Burstein, E.S., Friedman, H. and Greenblantt, D.J. : Simplified measurement of haloperidol by gas chromatography with nitrogen-phosphorus detection. J Chromatogr, 423, 380-382 (1987).
16. Ulrich, S., Meyer, F.P., Neuhof, S. and Knorr, W. : Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of eight schizophrenics. J Chromatogr B, 663, 289-296 (1995).
17. Tokunaga, H., Kudo, K., Imamura, T., Jitsufuchi, N. and Nagata, T. : Screening of antipsychotic drugs by wide-bore capillary gas chromatography with nitrogen phosphorus detection-Detection levels in plasma. Jpn J Legal Med, 50, 196-202 (1996).
18. Nilsson, L.B. : Reversed-phase ion pair liquid chromatographic method for the determination of low concentrations of haloperidol in plasma. J Chromatogr, 431, 113-122 (1988).
19. Park, K.H., Lee, M.H. and Lee, M.G. : Simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography. J Chromatogr, 572, 259-267 (1991).
20. Fang, J. and Gorrod, J.W. : High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations. J Chromatogr B, 614, 267-273 (1993).
21. Hariharan, M., Kindt, E.K., Van Noord, T. and Tandon, R. : An improved sensitive assay for simultaneous determination of plasma haloperidol and reduced haloperidol levels by liquid chromatography using a coulometric detector. Ther Drug Monit, 11, 701-707 (1989).
22. Eyles, D.E., Whiteford, H.A., Stedman, T.J. and Pond, S.M. : Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol. Psychopharmacology, 106, 268-274 (1992).
23. Aravagiri, M., Marder, S.R., Van Putten, T. and Marshall, B.D. : Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection: Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol. J Chromatogr B, 656, 373-381 (1994).
24. Igarashi, K. and Castagnoli, N., Jr. : Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr Biomed Appl, 579, 277-283 (1992).
25. Subramanyam, B., Woolf, T. and Castagnoli, N., Jr. : Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite. Chem Res Toxicol, 4, 123-128 (1990).